Loading...
Complications after CD19+ CAR T-Cell Therapy
SIMPLE SUMMARY: CD19+ Chimeric antigen receptor (CAR) T-cells are used against CD19+ hematologic malignancies, such as high-grade B-cell lymphoma and acute lymphoblastic leukemia. Since this is a relatively new treatment approach, not all potential side effects are well described, and the underlying...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699604/ https://ncbi.nlm.nih.gov/pubmed/33228221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113445 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|